Integrated Transcriptomic Analysis Identifies TAP1 as a Key Regulator of PANoptosis in Diabetic Kidney Disease Tubular Injury
Open Access
- 22 January 2026
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Abstract
Tubular injury is a key driver of diabetic kidney disease (DKD) progression. However, the involvement and regulatory mechanisms of PANoptosis in diabetic tubular injury remain poorly defined. Utilizing transcriptomic datasets from DKD renal tubules, we identified differentially expressed genes (DEGs) through limma analysis and co-expression modules via weighted gene co-expression network analysis (WGCNA). These findings were intersected with a comprehensive PANoptosis-related gene set. Hub genes were further prioritized using machine learning algorithms, including LASSO regression and random forest. Validation was conducted through the Nephroseq database, single-cell RNA sequencing (scRNA-seq) analysis and experimental studies in high glucose-treated tubular cells, DKD mice, and human DKD biopsies. Furthermore, functional enrichment and immune infiltration analyses were performed to elucidate biological implications. We revealed 1,624 DEGs and two key WGCNA modules significantly associated with DKD. Among 31 PANoptosis-related DEGs, machine learning prioritized three hub genes (TAP1, CASP1, PRKX), all of which were significantly upregulated in DKD and exhibited negative correlations with glomerular filtration rate. Functional analyses linked these hub genes to inflammatory and immune responses and scRNA-seq data confirmed their overexpression in proximal tubular cells. Moreover, experimental validation consistently demonstrated TAP1 upregulation in tubular cells under high glucose conditions, kidney tissues from DKD mouse models and human DKD biopsy samples. Our integrated analysis identifies TAP1 as a crucial regulator of PANoptosis in injured renal tubules of DKD, providing novel mechanistic insights into the pathogenesis of tubular injury and a potential therapeutic target for future research.Keywords
Funding Information
- The National Natural Science Foundation of China (81873604)
- Chongqing medical scientific research project (2022GDRC005)
- Chongqing Natural Science Foundation (CSTB2022NSCQ-MSX0984)
- the CQMU Program for Youth lnnovation in Future Medicine (W0173)
This publication has 48 references indexed in Scilit:
- Emerging role of PANoptosis in kidney diseases: molecular mechanisms and therapeutic opportunitiesApoptosis, 2025
- High glucose-induced senescence contributes to tubular epithelial cell damage in diabetic nephropathyExperimental Gerontology, 2024
- Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NFκB signaling pathwayCellular and Molecular Life Sciences, 2024
- Implications of inflammatory cell death-PANoptosis in health and diseaseArchives of Pharmacal Research, 2024
- Identification and analysis of diverse cell death patterns in diabetic kidney disease using microarray-based transcriptome profiling and single-nucleus RNA sequencingComputers in Biology and Medicine, 2023
- Renal tubular epithelial cells are constitutive non-cognate stimulators of resident T cellsCell Reports, 2023
- Shedding new light on the role of ERAP1 in Type 1 diabetes: A perspective on disease managementAutoimmunity Reviews, 2023
- Constructing bi-plots for random forest: TutorialAnalytica Chimica Acta, 2020
- PRKX, a Novel cAMP-Dependent Protein Kinase Member, Plays an Important Role in DevelopmentJournal of Cellular Biochemistry, 2016
- Overview of LASSO-related penalized regression methods for quantitative trait mapping and genomic selectionTheoretical and Applied Genetics, 2012